Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.9%

1 terminated out of 53 trials

Success Rate

94.4%

+7.9% vs benchmark

Late-Stage Pipeline

9%

5 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed with results

Key Signals

1 with results94% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (21)
Early P 1 (1)
P 1 (1)
P 2 (10)
P 3 (5)

Trial Status

Completed17
Recruiting15
Unknown8
Not Yet Recruiting6
Active Not Recruiting5
Suspended1

Trial Success Rate

94.4%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT07540260Not ApplicableRecruitingPrimary

CAIX PET/ CT Guided Radiation Therapy in CcRCC.

NCT05743569Active Not Recruiting

3D Specimen Maps for RT Planning

NCT03042156Completed

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

NCT02422550RecruitingPrimary

Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

NCT06746428Not ApplicableRecruitingPrimary

Activity Coaching During Pelvic Radiation Therapy

NCT04983095Not ApplicableRecruiting

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

NCT07415681Phase 2Not Yet Recruiting

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

NCT06159335Phase 3Recruiting

18F-FLUC PET/MR in Patients With Brain Mets

NCT06546592Not ApplicableRecruiting

Locally Optimised Contouring With AI Technology for Radiotherapy

NCT06583070RecruitingPrimary

SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

NCT06579248Early Phase 1Recruiting

Intraoral Hypothermia Device for Preserving Taste During Radiation

NCT05351294Phase 3SuspendedPrimary

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

NCT07324577Not ApplicableNot Yet RecruitingPrimary

Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing Radiotherapy

NCT07279077Phase 2Recruiting

Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial

NCT05721053Active Not Recruiting

Improving Outcomes for Older Adults Undergoing Radiation Therapy

NCT06128863Phase 2Active Not Recruiting

Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial

NCT07005882Phase 2Not Yet Recruiting

Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Radiotherapy

NCT05406063Not ApplicableRecruitingPrimary

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases

NCT06946420Phase 3Active Not RecruitingPrimary

SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy

NCT06864533Not ApplicableRecruiting

Adjuvant Chemotherapy for High Malignant Prostate Cancer

Scroll to load more

Research Network

Activity Timeline